Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Application of radiosensitizers in cancer radiotherapy
Food and Drug Administration (FDA) in May 2022 for the treatment of type 2 diabetes [1]
retatrutide is an unapproved research substance and not a substitute for an approved medicine
same active ingredient as Ozempic and Wegovy, but not FDA-approved Brand-Name Options (for eligible patients): Wegovy (semaglutide, FDA-approved for weight loss), Ozempic (semaglutide, off-label for weight loss), Zepbound and Mounjaro (tirzepatide), generic liraglutide (daily injection) Oral Medication Kits (non-injectable): Personalized oral combinations of naltrexone + bupropion, with options to add metformin or topiramate from $69/month as a 10-month prepaid plan App and Support Features: Access to the Hers app, including dynamic protocols to help improve nutrition, movement, and sleep-based habits for sustained weight loss Prescription anti-nausea medication (ondansetron) is included for eligible patients on GLP-1 injections at no extra cost 24/7 provider messaging access included Hers reports that on average, customers lost 11.1 lbs with compounded GLP-1 injections and 7.9 lbs with oral medication kits in the first two months of treatment alongside a reduced-calorie diet and exercise
L-carnitine is known to boost mitochondrial function and lessen decay
Oral BPC-157 capsules exist and have some utility for gut-specific indications because of localized activity in the GI tract
US$ 22.61
US$ 25.13
US$ 28.18
US$ 27.77
US$ 27.69
